Surge in demand for affordable medicine is driving the growth in Global Molecular Pharming Market in the forecast period, 2022-2026.
Moreover, surge in the demand of the affordable and effective medication is also driving the growth of the global molecular pharming market in the upcoming five years. Additionally, increasing instances of chronic diseases among all sections of the society is further aiding the growth of the global molecular pharming market in the next five years. Also, demand for herbal and organic products, and medicines is rapidly increasing thereby supporting the growth of the global molecular pharming market in the future five years. Furthermore, the rising awareness about the ayurvedic medicines, advantages of plants-based medication and herbal products is further substantiating the growth of the global molecular pharming market in the forecast period until 2026.
Molecular pharming is defined as the production of recombinant pharmaceuticals through plant biotechnology. The process has the potential to transform the pharmaceutical sector by making available of the drugs that are highly effective as well as affordable to every section of the society. The use of plants to express proteins is more practical, safe, efficient, and cost effective. The production of the biologics in the plant system to minimize the cost of microbial systems is termed as molecular pharming.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Molecular pharming Market"
https://www.techsciresearch.com/report/molecular-pharming-market/7873.html
The global molecular pharming market segmentation is based on crop source, technology, application, end user, competitional landscape, and regional distribution. Based on application, the market is further segmented into recombinant antibodies, hormones, vaccines, industrial enzymes, proteins & protein-based materials, technical reagents, nutritional products, and others. Recombinant antibodies are monoclonal antibodies which are generated in vitro using synthetic genes.
The production of recombinant proteins in the plant via process of molecular pharming can produce large quantities of medicinal polypeptides for the diagnosis and treatment of many diseases. For the production of antibodies in transgenic plants, plants are infected by engineered plant viruses and multiplied in plant cell culture. Plants hormones bring the qualities of rapid growth and proteins produced increases the plant growth the property is used in the pharmaceutical products too. Similarly, plant vaccines are also more beneficial, long lasting, have better result thus being used in the molecular pharming.
Based on end user, the market is further bifurcated into biotechnology & pharmaceutical companies, contract manufacturing organizations, and others. Biotechnology & pharmaceutical companies are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the account of increased uses of molecular pharming in production of precision medicine, genomic medicine, and to reduce the manufacturing cost of the pharmaceuticals and related products.
Moreover, the advancing technologies are further aiding the growth of the global molecular pharming market in the next five years. Surging demands from the pharmaceutical industries is also substantiating the growth of the global molecular pharming market in the next five years.
Meristem Therapeutics S.A. (Ventria Bioscience), Moolec Science Limited, Leaf Systems International Limited, Agrenvec S.L., Diamante SRL, ORF Genetics, Pfizer, Inc., Medicago Inc., Protalix Biotherapeutics, Inc., ProdiGene Inc., are some of the market players holding the major shares of the global molecular pharming market. Market players are actively involved in the research and technological development in the product developments.
The advanced technology has made it possible for the industry to provide excellent services through molecular pharming. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7873
Customers can also request for 10% free customization on this report.
“North America is the most promising region in terms of the future market growth. The market growth is anticipated on the backbone of advancing healthcare industry in the countries like United States, Canada. Moreover, research and technological advancement is rapidly increasing in the region and aiding the growth of the market. The combination of technology for the advanced plant biotechnological practices combined with the advanced agricultural practices is also aiding the growth of the global molecular pharming market in the future five years. New market players must focus on the extended research and advancing technologies using the plant system making it efficient and cheaper option for the mass production of the various pharmaceutical and biologics. Financial investment and favorable policies for the pharmaceutical production would also support the future market growth,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Molecular Pharming Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Crop Source (Maize, Barley, Tobacco, Safflower, Rice, Alfalfa), By Technology (Gene Gun, Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer, Others), By Application (Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Products, Others), By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others), By Region”, has evaluated the future growth potential of global molecular pharming and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global molecular pharming market.
Browse Related Reports:
Global Organic Farming Market By Type (Pure Organic Farming v/s Integrated Organic Farming) By Method (Crop Rotation, Polyculture, Mulching, Cutting, Composting, Weed Management, Soil Management, Others) By Land Area (Up to 1 Hectare, 1.1-5 Hectare, 5.1-10 Hectare, 10.1-30 Hectare) By Ownership (Contract Farming v/s Inhouse) By Crop Type (Oilseeds & Pulses, Cereals & Grains, Fruits & Vegetables, Others) By Company, By Region, Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/organic-farming-market/7745.html
Israel Precision Farming Market By Component (Hardware; Software; Services) By Hardware (Automation and Control Systems v/s Sensing & Monitoring Devices) By Software (Web Based v/s Cloud Based) By Services (System Integration & Consulting; Maintenance & Support; Professional & Managed Services) By Technology (Guidance System; Remote Sensing; Variable Rate Technology) By Application (Yield Monitoring; Field Mapping; Crop Scouting; Weather Tracking; Irrigation Management; Farm Labor Management; Others), By Region, Company Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/israel-precision-farming-market/7644.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
No comments:
Post a Comment